This is a 1-hour video that shows Daniel Vasella, Novartis Chairman and CEO, who was named by Financial Times Survey as the most influential European business leader in the last quarter of the 20th century, lecturing at a MIT conference about innovation. He focuses on a case study of one of Novartis flagship pharmaceuticals, Gleevec. He talks about the discovery, development and marketing of this drug, which fights the rare chronic myeloid leukemia (CML).